Kamada

$6.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-3.73%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Kamada and other stocks, options, and ETFs commission-free!

About KMDA

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel. The listed name for KMDA is Kamada Ltd. Ordinary Shares.

CEO

Amir London

Employees

429

Headquarters

Rehovot, HaMerkaz

Founded

1990

Market Cap

305.55M

Price-Earnings Ratio

14.38

Dividend Yield

—

Average Volume

165.71K

High Today

$7.15

Low Today

$6.85

Open Price

$7.11

Volume

159.31K

52 Week High

$13.33

52 Week Low

$4.40

Collections

KMDA Earnings

$0.00

$0.05

$0.10

$0.15

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 11, Pre-Market